---
figid: PMC7353835__10067_2020_5275_Fig1_HTML
figlink: pmc/articles/PMC7353835/figure/Fig1/
number: F1
caption: Virchow’s triad in the thrombogenesis in COVID-19. Virchow’s triad consists
  of abnormal vessel wall (endotheliitis, endothelial dysfunction with loss of glycocalyx,
  endothelial disruption), abnormal flow (due to hyper-viscosity, immune activation,
  high fibrinogen, impaired microcirculation due to hypoxia and turbulent flow due
  to microthrombi), and hypercoagulable state (inhibition of plasminogen system due
  to unopposed canonical renin-angiotensin pathway, platelet dysfunction, complement
  activation (not shown), and hyperimmune response)
pmcid: PMC7353835
papertitle: Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of
  Virchow’s triad.
reftext: Sakir Ahmed, et al. Clin Rheumatol. 2020 Jul 11 :1-15.
pmc_ranked_result_index: '16929'
pathway_score: 0.9432962
filename: 10067_2020_5275_Fig1_HTML.jpg
figtitle: Virchow’s triad in the thrombogenesis in COVID-19
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7353835__10067_2020_5275_Fig1_HTML.html
  '@type': Dataset
  description: Virchow’s triad in the thrombogenesis in COVID-19. Virchow’s triad
    consists of abnormal vessel wall (endotheliitis, endothelial dysfunction with
    loss of glycocalyx, endothelial disruption), abnormal flow (due to hyper-viscosity,
    immune activation, high fibrinogen, impaired microcirculation due to hypoxia and
    turbulent flow due to microthrombi), and hypercoagulable state (inhibition of
    plasminogen system due to unopposed canonical renin-angiotensin pathway, platelet
    dysfunction, complement activation (not shown), and hyperimmune response)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACE
  - ATR
  - SERPINE1
  - Hydroxychloroquine
  - Aldosterone
  - Statins
  - Spironolactone
  - Baricitinib
  - Tumour Necrosis
  - Hypoxia
genes:
- word: ACE1/Ang-II/
  symbol: ACE1
  source: hgnc_alias_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: PAI-1
  symbol: PAI1
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINE1
  entrez: '5054'
chemicals:
- word: Hydroxychloroquine
  source: MESH
  identifier: D006886
- word: Aldosterone
  source: MESH
  identifier: D000450
- word: Statins
  source: MESH
  identifier: D019821
- word: Spironolactone
  source: MESH
  identifier: D013148
- word: Baricitinib
  source: MESH
  identifier: C000596027
diseases:
- word: Tumour Necrosis
  source: MESH
  identifier: D009336
- word: Hypoxia
  source: MESH
  identifier: D000860
figid_alias: PMC7353835__F1
redirect_from: /figures/PMC7353835__F1
figtype: Figure
---
